
United States operational
LambdaVision
LambdaVision, founded in 2009 and headquartered in Farmington, Connecticut, is a biomedical company developing protein-based artificial retinas to restore functional vision to patients with degenerative retinal diseases — and pioneering manufacturing these implants in microgravity on the International Space…
- Headquarters
- Farmington, United States
- Founded
- 2009
- Type
- commercial
- Founded
- 2009
- Headquarters
- Farmington, United States
- Ownership
- Private
Quick Facts
About LambdaVision
LambdaVision, founded in 2009 and headquartered in Farmington, Connecticut, is a biomedical company developing protein-based artificial retinas to restore functional vision to patients with degenerative retinal diseases — and pioneering manufacturing these implants in microgravity on the International Space Station, because the zero-gravity environment enables a film deposition quality impossible to achieve in Earth's gravitational field.
LambdaVision's retinal implant technology is based on bacteriorhodopsin (bR) — a light-sensitive protein found in certain archaea that acts as a natural light-to-proton pump, converting photons into electrical signals that can stimulate retinal neurons. The artificial retina consists of hundreds of alternating polymer and bacteriorhodopsin protein layers built up through a layer-by-layer deposition process where each layer must be extremely uniform for the device to produce consistent signal output across the implant's active area.
On Earth, gravity causes protein molecules to aggregate and settle unevenly during the layer-by-layer deposition process, creating non-uniform film thicknesses that reduce device performance and reproducibility. In microgravity, protein molecules remain randomly distributed in solution, depositing uniformly across the substrate surface and producing films with significantly better thickness uniformity and optical quality. ISS experiments demonstrated that microgravity-manufactured bR films had measurably superior uniformity compared to Earth-manufactured controls — providing the scientific basis for manufacturing production batches in space.
With 9 ISS missions completed by 2025, LambdaVision has validated the microgravity manufacturing advantage through repeated experiments with increasing sophistication. The company raised $7 million in additional funding in 2025 to advance toward clinical-grade implant manufacturing. LambdaVision represents a leading example of in-space manufacturing for high-value biomedical products, a market that could justify the economics of dedicated commercial space manufacturing platforms like Varda Space Industries and Space Forge are building.
Signals
- Verification
- Awaiting review
Categories & Capabilities
Industry Categories
Quick Facts
Links
Location
Loading map...
Share
Suggest an Edit
Is this information outdated or incorrect? Help us improve this profile.
Submit CorrectionExplore more
Search the full directory
Similar Companies
Other companies in in-space-manufacturing
Rhodium Scientific
Rhodium Scientific is a Houston-based space biotechnology company, founded in 2014 by CEO Olivia Gamez Holzhaus, that pr...
Eascra Biotech
Eascra Biotech manufactures therapeutic nanoparticles in microgravity. Its Janus base nanomaterials are synthetic molecu...
Sierra Space Life Sciences
Sierra Space Life Sciences is the biotechnology and microgravity research division of Sierra Space, the commercial space...
Ecoatoms
Ecoatoms is a Reno, Nevada startup, founded in 2022, that builds AI-driven automated payloads and onboard computers for ...
Solar Foods
Solar Foods, founded in 2017 and based in Espoo, Finland, is a food technology company pioneering novel protein producti...
Redwire
Redwire Corporation is a leading space infrastructure company pioneering in-space manufacturing, 3D bioprinting, and adv...
Also in United States
Other space companies based in United States
Frequently asked about LambdaVision
Quick answers to the questions readers most often search for.
- When was LambdaVision founded?
- LambdaVision was founded in 2009 in United States.
- Where is LambdaVision headquartered?
- LambdaVision is headquartered in Farmington, United States.
- What does LambdaVision do?
- LambdaVision, founded in 2009 and headquartered in Farmington, Connecticut, is a biomedical company developing protein-based artificial retinas to restore functional vision to patients with degenerative retinal diseases — and pioneering manufacturing these implants in microgravity on the International Space Station, be…
- Is LambdaVision a public or private company?
- LambdaVision is a privately held company and is not listed on any stock exchange.
- What sector does LambdaVision operate in?
- LambdaVision works in in-space manufacturing and Biotechnology.
Data Accuracy Notice: Information about LambdaVision is compiled from publicly available sources including company websites, press releases, regulatory filings, and industry reports. Data is reviewed periodically but may not reflect the most recent developments.
